Keywords: astellas, conduct, multicenter, asian, trial, factor, xa

Astellas to conduct multicenter Asian trial of Factor Xa inhibitor - YM150

Article | 27 November 2006

Print This

Japan's Astellas Pharma, the country's second largest drugmaker by sales, has announced that it will undertake an international Phase II ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in